A carregar...
Pembrolizumab in the adjuvant treatment of melanoma: efficacy and safety
INTRODUCTION: Regional or distant metastases from melanoma may be surgically resected, but remain at high-risk of recurrence. Over the last few years, several treatments have been approved to mitigate this risk. These include anti-PD-1 agents, specifically pembrolizumab and nivolumab. AREAS COVERED:...
Na minha lista:
| Publicado no: | Expert Rev Anticancer Ther |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8238788/ https://ncbi.nlm.nih.gov/pubmed/33504219 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14737140.2021.1882856 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|